SC 13G: aTYR PHARMA INC

AI Summary

SC 13G filing by aTYR PHARMA INC.

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securitie

Filing Documents

• p24-2974sc13g.htm (SC 13G) — 62KB
• p24-2974exhibit99.htm (EX-99) — 6KB
• 0000902664-24-005837.txt ( ) — 70KB

(a)

Item 1(a). Name of Issuer. aTyr Pharma, Inc. (the " Issuer ").

(b)

Item 1(b). Address of Issuer's Principal Executive Offices. 10240 Sorrento Valley, Suite 300, San Diego, CA 92121.

(a)

Item 2(a). Name of Person Filing. This statement is filed by: (i) Point72 Asset Management, L.P. (" Point72 Asset Management ") with respect to shares of common stock, par value $0.001 per share (" Shares "), of the Issuer held by Point72 Associates, LLC, an investment fund it manages (" Point72 Associates "); (ii) Point72 Capital Advisors, Inc. (" Point72 Capital Advisors Inc .") with respect to Shares held by Point72 Associates; and (iii) Steven A. Cohen (" Mr. Cohen ") with respect to Shares beneficially owned by Point72 Asset Management and Point72 Capital Advisors Inc. Each of Cubist Systematic Strategies, LLC and Point72 Asia (Singapore) Pte. Ltd. are advisors under common control with Point72 Asset Management, and each acts as a sub-advisor with respect to a portion of the Shares reported herein. Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1 , pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

(b)

Item 2(b). Address of Principal Business Office. The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902.

(c)

Item 2(c). Place of Organization. Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen.

(d)

Item 2(d). Title of Class of Securities. Common Stock, par value $0.001 per share.

(e)

Item 2(e). CUSIP Number. 002120202 Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a: Not applicable. Item 4. The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person. Such information is as of the close of business on October 14, 2024. CUSIP No. 002120202 13G Page 6 of 7 Pages Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own directly no Shares. Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power with respect to the securities held by Point72 Associates. Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management. Mr. Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc. The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Shares reported herein. The aggregate percentage of the Shares reported to be beneficially owned by each Reporting Person is based on 80,796,198 Shares outstanding which is the sum of: (i) 75,796,198 Shares outstanding as of August 9, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, filed with the Securities and Exchange Commission on August 13, 2024; and (ii) 5,000,000 Shares purchased by Point72 Associates in the at the market offering by the Issuer. Item 5. If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6.

View Full Filing

View this SC 13G filing on SEC EDGAR